Bolsonaro celebrated the haltering of the clinical trial of the Chinese vaccine Sinovac in the middle of a pandemic, which has already killed more than 160 thousand Brazilians, due to the death of one of the volunteers.
On Monday night, the Brazilian Health Regulatory Agency (Anvisa) said that a "serious adverse event" was putting a suspension of the 3rd phase of studies for the vaccine, which is being produced by the Butantan Institute in partnership with the Chinese pharmaceutical company.
According to medical authorities, the volunteer’s death was unrelated to the clinical trials. The death of the volunteer was caused by suicide.